Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06436820
Other study ID # 310393.
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 2024
Est. completion date November 2025

Study information

Verified date May 2024
Source Guy's and St Thomas' NHS Foundation Trust
Contact Kin Sheng Lim
Phone 02071884885
Email sheng.lim@gstt.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)). Through observing changes in aqueous outflow facility in patients scheduled for lumbar Puncture (LP) as part of their routine care the objectives we aim to answer include: - Investigating the effect of lumbar puncture induced reduction in ICP on patients with known or suspected IIH, compared to control patients, who will be receiving LP for reasons not pertaining to high pressure. - Comparing pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients. Outside of the standard care provided for these patients as part of their scheduled lumbar puncture, they will have measurements of their eye taken before and after their lumbar puncture.


Description:

This study aims to investigate the relationship between intracranial pressure (ICP) and aqueous outflow (the flow of the eye's internal fluid out of the eye), in patients with increased intracranial pressure (idiopathic intracranial hypertension (IIH)). The effect of lowering intracranial pressure on aqueous outflow will be examined by taking additional measurements before and after a procedure called a lumbar puncture (LP). These measurements include a scan to measure the dimensions of the eye, intraocular pressure reading, and a non-invasive technique to measure aqueous outflow (electronic Schiotz tonography) which is used regularly in the eye research unit at St Thomas' Hospital. Study participants will already be scheduled for a lumbar puncture as they have known or suspected IIH, and LP is routinely used to investigate this. Additionally, control participants having LP for reasons not pertaining to a condition that may elevate intracranial pressure will also be included. Study participants will finish their involvement following the second aqueous outflow reading, after their LP. A lumbar puncture procedure directly measures the intracranial pressure, but also reduces the pressure in the process. If aqueous outflow is measured before and after lumbar puncture, it will provide more information about whether the change in intracranial pressure affects the intraocular pressure due to a change in the rate of fluid flowing out of the eye. If a relationship between intracranial pressure and aqueous outflow is found to be present, it may offer an alternative non-invasive measurement for intracranial pressure. Additionally, this study would highlight an avenue of investigation into dysregulation of intraocular pressure in conditions such as glaucoma. Similarly, negative findings would help inform ongoing discussions and controversies in the literature regarding relationships between intraocular pressure and intracranial pressure.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 66
Est. completion date November 2025
Est. primary completion date November 2025
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Males or female between the ages of 18 and 80 (inclusive). - Able to understand the study and give informed consent. - Willing, able and available to participate in all aspects of the study. - Able to undergo accurate tonography. - Diagnosis of Idiopathic intracranial hypertension (IIH) or suspected diagnosis of IIH as determined by a consultant subspecialist neurologist or neuro-ophthalmologist. Control group will only include: - Individuals requiring lumbar puncture as part of their standard care for reasons other than suspected raised intracranial pressure e.g. for cerebrospinal fluid (CSF) sampling to analyse oligoclonal bands or other conditions necessitating lumbar puncture for diagnostic/prognostic purposes. - Individuals suspected of having a raised intracranial pressure but, upon measurement of the opening pressure, are found to have an intracranial pressure within normal limits.* - In this study, where there are considered to be signs of raised intracranial pressure as judged by a consultant neuro ophthalmologist or neurologist, in combination with an opening CSF pressure 20cmH2O or greater, this will be taken as a raised intracranial pressure. Normal CSF pressure is taken as 19cmH2O or lower. In asymptomatic patients, pressures of up to 25cmH2O will be considered normal. Exclusion Criteria - Under 18 or over 80 years of age. - Diagnosis of ocular hypertension (ocular hypertension is defined as any individual with an intraocular pressure above 24mmHg measured on Goldman tonometry, irrespective of corneal thickness. This applies to intraocular pressure measured historically as well on the day of assessment). - Diagnosis of glaucoma of any subtype (glaucoma is defined on the basis of any glaucomatous optic nerve head appearance [including that defined on the basis of optic nerve head optical coherence tomography] or visual field defect, irrespective of intraocular pressure). - Diagnosis of any significant retinal, corneal or other ocular abnormality aside from optic nerve head oedema secondary to raised ICP. - Previous intraocular surgery or any surgery in which the conjunctiva has been breached e.g. optic nerve sheath fenestration or squint surgery. - Diagnosis of raised intracranial pressure secondary to space occupying lesions. - Any central nervous system or other systematic disorder that is likely to make lumbar puncture high risk or likely to render accurate recording of opening pressures unreliable. - Mental impairment conflicting with informed consent. - Patients who might not adequately understand written information given in English or verbal explanations in English will not be included as participants in the study must be able to understand English to complete some of the tests. - Participants will not be included if they are involved in research deemed by the investigators to impact the outcomes of this study.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Lumbar puncture
Lumbar puncture procedure performed within a clinical setting

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Guy's and St Thomas' NHS Foundation Trust

Outcome

Type Measure Description Time frame Safety issue
Primary Measure the effect of LP induced change in intracranial pressure on outflow facility in patients with idiopathic intracranial hypertension compared to control patients To investigate the effect of lumbar puncture induced changes in intracranial pressure on aqueous outflow facility in patients with known or suspected idiopathic intracranial hypertension, compared to control patients. 18 Months
Secondary Measure the difference in outflow facility between patients with idiopathic intracranial hypertension and control patients prior to lumbar puncture To compare pre lumbar puncture aqueous outflow facility between patients with idiopathic intracranial hypertension and control patients. 18 Months
See also
  Status Clinical Trial Phase
Terminated NCT01863381 - Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement N/A
Recruiting NCT06027567 - The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure Phase 4
Active, not recruiting NCT02896452 - Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
Recruiting NCT06059703 - Biomarkers in the Etiology of Idiopathic Intracranial Hypertension N/A
Terminated NCT05347147 - A Trial to Determine the Efficacy and Safety of Presendin in IIH Phase 3
Not yet recruiting NCT06361823 - Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment Phase 3
Active, not recruiting NCT02124486 - An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH N/A
Recruiting NCT02143258 - Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension N/A
Enrolling by invitation NCT05308823 - Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension N/A
Not yet recruiting NCT05762367 - MR Lymphatic Imaging in Idiopathic Intracranial Hypertention N/A
Completed NCT03867461 - The Effects of MAP and EtCO2 on Venous Sinus Pressures N/A
Completed NCT03963336 - Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension Early Phase 1
Completed NCT01003639 - Idiopathic Intracranial Hypertension Treatment Trial Phase 2/Phase 3
Recruiting NCT03096743 - Evaluating Raised Intracranial Pressure Using MR Elastography N/A
Completed NCT04314128 - Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler N/A
Terminated NCT03501966 - Surgical Idiopathic Intracranial Hypertension Treatment Trial Phase 3
Active, not recruiting NCT03556085 - Venous Sinus Stenting With the River Stent in IIH N/A
Completed NCT02017444 - Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. Phase 2